Work

Implementing platform-based technologies to scale viral vector manufacturing consistently and efficiently

Year: 2024

Type: article

Abstract: Although advancements in viral vector manufacturing have enabled significant progress in cell and gene therapies, the field continues to face challenges in ensuring vector productivity and purity as manufacturing scales up. Abi Pinchbeck, Editor of BioInsights, speaks with Xueyuan Liu, Director of the Research Vector Core at Children’s Hospital of Philadelphia, about strategies for overcoming these challenges, including innovations in process optimization, vector design, and advanced analytical tools to enhance the clinical and commercial potential of viral vectors.

Source: Cell and Gene Therapy Insights

DOI: 10.18609/cgti.2024.183

Author: Xueyuan Liu

Institution: Children's Hospital of Philadelphia

Language: English

Topic: Virus-based gene therapy research

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: hybrid

OpenAlex ID: W7115569710

FWCI:

Cites:

Cited by:

Related to: